CMR Surgical today unveiled its portable Versius robotic surgical platform, designed for use in minimal-access procedures.
The U.K.-based company said that the Versius robotic platform’s design is inspired by the human arm, and is intended to be affordable and transportable due to its small size and modular design.
CMR Surgical said that it hopes the Versius system, which is currently undergoing validation studies intended to support regulatory approval, will help to remove current barriers to robotic and minimal access surgical procedures.
“We believe Versius represents a paradigm shift in surgery. The ground-breaking design, coupled with genuine affordability, means that patients everywhere have the potential to benefit from the advantages of minimal access surgery. Versius is a great example of British innovation and its launch represents a pivotal moment in the next chapter of surgery and patient care,” CEO Martin Frost said in a press release.
In June, CMR Surgical said that it closed a $100 million Series B round of funding to support commercialization of its Versius robotic surgical system.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.